Close

Glioma

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

A glioma is a type of tumor that occurs in the brain or spine, which arises from glial cells. Based on the histological features, Gliomas are mainly classified into ependymomas (develop in ependymal cells), astrocytomas (develop in astrocytes), Oligodendrogliomas (develop in oligodendrocytes), brainstem glioma (develop in the brain stem), Optic nerve glioma (develop in or around the optic nerve) and mixed gliomas (develop in other different types of glia). Because the sites of affected central nervous system are various, the symptoms of gliomas are different. For instance, a glioma in the brain can result in headaches, vomiting, seizures, and cranial nerve disorders caused by increased intracranial pressure. A glioma developing in the optic nerve can cause visual loss. Treatment for gliomas depends on the location of cancer, the cell types, and the grade of disease. Normally, surgery, radiation therapy, and chemotherapy with a combined approaches are used. Considering that these traditional methods have certain side effects, we provide CellRapeutic™ CAR products targeting glioma-specific antigens to assist your development of new treatments in clinical trials.

People classify Glioma into these types:

Ependymomas
Oligodendrogliomas
Optic nerve glioma
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.